intracranial hypertension stent

Intracranial pressure reduction stents are a therapeutic approach for managing intracranial hypertension, functioning by deploying stents within the cerebral vasculature to enhance blood flow and decrease intracranial pressure. This procedure is typically reserved for patients who have failed pharmacological treatment or are intolerant to it.

The criteria for intracranial pressure reduction stents encompass intracranial hypertension resulting from conditions such as intracranial arterial stenosis and intracranial venous sinus thrombosis. Prior to opting for stent therapy, physicians evaluate various aspects including the patient's medical history, age, and comorbidities to ascertain the suitability for stent placement.

The stent placement procedure is generally conducted under general anesthesia, utilizing a catheter to navigate the stent to the affected intracranial site, where it is then deployed to provide support to the vessel wall. Following the surgery, patients are closely monitored for vital signs and are prescribed anticoagulant medications to prevent thrombus formation under medical supervision.

While intracranial pressure reduction stents can effectively alleviate the symptoms of intracranial hypertension, they are not indicated for all patients. It is imperative for patients to be well-informed about the risks associated with the procedure and potential complications before consenting to treatment, with guidance from their healthcare provider. Furthermore, postoperative patients require regular check-ups to promptly identify and address any emerging issues.